Issue 44, 2023, Issue in Progress

Cobalt-assisted route to rare carbocyclic C-ribonucleosides

Abstract

(Re)emerging RNA viruses have been major threats to public health in the past years, and from the few drugs available, nucleoside analogues are still at the cornerstone of the antiviral therapy. Among them, the synthesis of carbocyclic C-nucleosides is suffering from long syntheses and poor yields. Herein we report a concise stereoselective synthesis of rare carbocyclic C-nucleosides (11a–l) bearing non-canonical nucleobases through a cobalt-assisted-route as key step starting from the optically pure (−)-cyclopentenone 1. This approach paves the route for novel carbocyclic C-nucleoside discovery.

Graphical abstract: Cobalt-assisted route to rare carbocyclic C-ribonucleosides

Supplementary files

Article information

Article type
Paper
Submitted
21 Jul 2023
Accepted
02 Oct 2023
First published
20 Oct 2023
This article is Open Access
Creative Commons BY license

RSC Adv., 2023,13, 30777-30786

Cobalt-assisted route to rare carbocyclic C-ribonucleosides

A. C. Ojeda-Porras, V. Roy, O. Bourzikat, P. Favetta and L. A. Agrofoglio, RSC Adv., 2023, 13, 30777 DOI: 10.1039/D3RA04937J

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements